Abstract
Based in high sensitivity and specificity reported recently in detection of the cancer, the technique of Raman spectroscopy is proposed to discriminate between breast cancer, leukemia and cervical cancer using blood serum samples from patients officially diagnosed. In order to classify Raman spectra, clustering method known as Super Paramagnetic Clustering based on statistical physics concepts with a stochastic approach was implemented. Comparing firstly average Raman spectra of the three cancers, some peaks that allowed differentiating one cancer from other were identified, however, other peaks allowed concluding that there are biochemical similarities among them. According to these spectra, the band associated with amide I (1654 cm−1) and one of two shoulders assigned to amide III (1230-1282 cm−1) allowed discriminating leukemia from breast and cervical cancer, whereas band 714 cm−1 (polysaccharides) achieves to differentiate cervical cancer from leukemia and breast cancer, and bulged region, 1040 − 1100 cm−1 (phenylalanine, phospholipid) discriminated breast cancer from leukemia and cervical cancer. Subsequently, Super Paramagnetic Clustering method was applied to Raman spectra to study similarity relationships between cancers based on the biochemical composition of serum samples. Finally, as a cross check method, the standard method to classify Raman spectra of breast cancer, leukemia and cervical cancer, known as principal components analysis, was used showing excellent agreement with results of Super Paramagnetic Clustering method. Preliminary results demonstrated that Raman spectroscopy and Super Paramagnetic Clustering method can be used to discriminate between breast cancer, leukemia and cervical cancer samples using blood serum samples.
Highlights
Some of the most deadly cancers affect different parts of the body, among them there are similarities of different types according to several reported researches, ie, these studies had found relationships between certain forms of breast, lung, colon, cervical cancers and leukemia
Discrimination between breast cancer, leukemia, cervical cancer based on blood serum samples Raman spectroscopy and Super Paramagnetic Clustering (SPC) method was studied
This tree structure showed that clusters corresponding to leucemia and cervical cancer spectra belonged to a larger cluster, which together with another one corresponding to breast cancer, make up the largest cluster formed by all the spectra, ie, leukemia maintains greater similarities with cervical cancer but without the loss of relationships between the three cancers
Summary
Some of the most deadly cancers affect different parts of the body, among them there are similarities of different types according to several reported researches, ie, these studies had found relationships between certain forms of breast, lung, colon, cervical cancers and leukemia. Cancer study using Raman spectroscopy and SPC method facilitate the comparison of therapeutic data bank between the cancers difficult to treat, suggesting that the treatments could be performed with the same chemotherapy drugs. In this sense, studies have showed that the human cervical cancer oncogene (HCCR) is over-expressed in human cervical cancer tissues and found to have high-level expression in various human malignancies including breast, kidney, stomach, colon, liver and ovarian cancer [1,2,3,4,5,6]. Later studies were able to show that expression levels of the HCCR mRNA are associated with clinical prognosis in patients with acute leukemia (AL) and they have explored the potential use as a biomarker for monitoring minimal residual disease (MRD) in AL [7]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.